SCHEMBL22075920

SCHEMBL22075920

O=C(O)NCCOCCOCCNC(=O)COc1ccc2c(c1)CCCN2C(=O)CCl

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PARP1 P09874 1/20 0.45
▸ PARP2 Q9UGN5 1/20 0.45
▸ ALDH1A1 P00352 4/20 0.43
▸ MEN1 O00255 2/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ MAPT P10636 4/20 0.42
▸ TP53 P04637 4/20 0.42
▸ TSHR P16473 3/20 0.42
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ NPC1 O15118 1/20 0.42
▸ RAB9A P51151 1/20 0.42
▸ PDK1 Q15118 2/20 0.42
▸ PDK2 Q15119 2/20 0.42
▸ PDK3 Q15120 2/20 0.42
▸ PDK4 Q16654 2/20 0.42
▸ CYP1A2 P05177 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ NCF1 P14598 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22075954 0.93 PARP1 (0.47) PARP1PARP2ALDH1A1MEN1KMT2A
SCHEMBL22075934 0.93 PARP1 (0.47) PARP1PARP2ALDH1A1MEN1KMT2A
SCHEMBL29040445 0.92 HPGD (0.46) PARP1PARP2ALDH1A1MEN1KMT2A
SCHEMBL30457557 0.92 HPGD (0.46) PARP1PARP2ALDH1A1MEN1KMT2A
SCHEMBL22075950 0.92 PARP1 (0.46) PARP1PARP2ALDH1A1MEN1KMT2A
SCHEMBL22111194 0.88 PDK2 (0.42) PARP1PARP2ALDH1A1MEN1KMT2A
SCHEMBL22075928 0.86 PARP1 (0.43) PARP1PARP2ALDH1A1MEN1KMT2A
SCHEMBL22075936 0.86 PARP1 (0.43) PARP1PARP2ALDH1A1MEN1KMT2A
SCHEMBL22075944 0.84 POLB (0.44) PARP1PARP2ALDH1A1MEN1KMT2A
SCHEMBL23499604 0.83 PARP1 (0.52) PARP1PARP2ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11691984-B2 Compounds and methods for DCAF-mediated protein degradation THE SCRIPPS RESEARCH INSTITUTE (US) 2023-07-04 — — US disclosed
US-20200190105-A1 COMPOUNDS AND METHODS FOR DCAF-MEDIATED PROTEIN DEGRADATION THE SCRIPPS RESEARCH INSTITUTE 2020-06-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200190105-A1 COMPOUNDS AND METHODS FOR DCAF-MEDIATED PROTEIN DEGRADATION DCAF1, CUL4A, DCAF15 PARP1 2265/4885PARP2 2327/4885ALDH1A1 2600/4885
US-11691984-B2 Compounds and methods for DCAF-mediated protein degradation DCAF1, CUL4A, DCAF15 PARP1 2265/4885PARP2 2327/4885ALDH1A1 2600/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback